Thu, May 19, 2022

Mayank Mamtani Maintained (XFOR) at Strong Buy with Decreased Target to $7 on, May 19th, 2022

Mayank Mamtani of B. Riley Securities, Maintained "X4 Pharmaceuticals, Inc." (XFOR) at Strong Buy with Decreased Target from $10 to $7 on, May 19th, 2022.

Mayank has made no other calls on XFOR in the last 4 months.



There are 2 other peers that have a rating on XFOR. Out of the 2 peers that are also analyzing XFOR, 0 agree with Mayank's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Mayank


  • Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $8.5 on, Friday, May 13th, 2022
  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $10 on, Tuesday, April 5th, 2022